{
    "Trade/Device Name(s)": [
        "Diazyme LDL-Cholesterol Reagent"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K073523",
    "Predicate Device Reference 510(k) Number(s)": [
        "K971573"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LBR",
        "JIS",
        "JIX",
        "JJX"
    ],
    "Summary Letter Date": "January 22, 2008",
    "Summary Letter Received Date": "November 15, 2007",
    "Submission Date": "November 12, 2007",
    "Regulation Number(s)": [
        "21CFR862.1475"
    ],
    "Regulation Name(s)": [
        "Lipoprotein Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Low Density Lipoprotein Cholesterol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzymatic assay",
        "Modified precipitation method",
        "Trinder reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Instrument",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme LDL-Cholesterol Reagent, an in vitro assay for LDL cholesterol quantification in serum or plasma",
    "Indications for Use Summary": "Intended for the in vitro quantitative determination of Low Density Lipoprotein Cholesterol in human serum or plasma to assist diagnosis and treatment of patients at risk for coronary heart disease",
    "fda_folder": "Clinical Chemistry"
}